MicroSteer
Endoscopic Add-on Device for the Removal of Complex Lesions
Company Overview
Snapshot
Founded in January 2023 by Ofer Pillar and Adi Strauss, MicroSteer operates with 1–10 employees. The company secured its initial funding in January 2023, with NGT HealthCare II participating in its Pre-Seed round.
Business overview
MicroSteer is developing a robotic system designed for the endoscopic removal of complex gastrointestinal tumors, aiming to provide an alternative to open or laparoscopic surgeries. The company's core product, Phalcon-1, is positioned as the first steered polypectomy device, enhancing safety and speed for endoscopists. MicroSteer serves the healthcare industry, specifically targeting gastroenterologists and surgeons, within the Medical Devices and Medical Treatment & Therapeutics sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is MicroSteer's primary focus?
- MicroSteer is focused on developing a robotic system for the endoscopic removal of complex gastrointestinal tumors, aiming to provide a less invasive alternative to traditional surgeries.
- When was MicroSteer founded?
- MicroSteer was founded in January 2023.
- Who are the founders of MicroSteer?
- MicroSteer was founded by Ofer Pillar and Adi Strauss.
- What is the name of MicroSteer's primary product?
- MicroSteer's primary product is the Phalcon-1, a steered polypectomy device designed to enhance the endoscopic removal of complex gastrointestinal tumors, making procedures safer and faster.